Search results
Results From The WOW.Com Content Network
Sir Demis Hassabis (born 27 July 1976) is a British artificial intelligence (AI) researcher, and entrepreneur. He is the chief executive officer and co-founder of Google DeepMind , [ 8 ] and Isomorphic Labs , [ 9 ] [ 10 ] [ 11 ] and a UK Government AI Adviser. [ 12 ]
Demis Hassabis cofounded DeepMind, the renowned AI lab acquired by Google in 2014. He is also a former chess prodigy and won the Nobel Prize for Chemistry.
DeepMind Technologies Limited, [1] trading as Google DeepMind or simply DeepMind, is a British-American artificial intelligence research laboratory which serves as a subsidiary of Alphabet Inc. Founded in the UK in 2010, it was acquired by Google in 2014 [8] and merged with Google AI's Google Brain division to become Google DeepMind in April 2023.
Demis Hassabis and a fellow DeepMinder, John Jumper, won one-half of the Nobel Prize in chemistry. ... Google acquired the startup for $400 million in 2014 and merged it with Google AI's division ...
Google suddenly finds itself with two Nobel laureates on its staff. On Wednesday, the Royal Swedish Academy of Sciences announced that Demis Hassabis and John Jumper are recipients of this year ...
[2] [3] [4] Isomorphic Labs was founded by Demis Hassabis, who also serves as the CEO. [ 5 ] [ 3 ] The company was incorporated on February 24, 2021 [ 1 ] and announced on November 4, 2021. [ 6 ] It was established under Alphabet Inc. as a spin-off from its AI research lab DeepMind , of which Hassabis is also founder and CEO.
STOCKHOLM (Reuters) -U.S. scientists David Baker and John Jumper and Briton Demis Hassabis won the 2024 Nobel Prize in Chemistry on Wednesday for work on decoding the structure of proteins and ...
Baker works at the University of Washington in Seattle, while Hassabis and Jumper both work at Google Deepmind in London. Baker designed a new protein in 2003 and his research group has since produced one imaginative protein creation after another, including proteins that can be used as pharmaceuticals, vaccines, nanomaterials and tiny sensors ...